Rapid-onset dystonia-parkinsonism (RDP) is a rare form of hereditary dystonia caused by loss-of-function mutations of the Na + /K + -ATPase α3 isoform (ATP1α3). An acute onset of generalized dystonia and parkinsonism after exposure to stress and an incomplete disease penetrance is described in RDP, thereby suggesting a geneenvironmental interaction in individuals with a genetic predisposition for dystonia development. Dystonia is considered a central motor network disease and in line with this concept, alterations in cerebellar neuronal firing have been described in RDP mouse models, but the pathogenic role of the basal ganglia remains unclear. We have mimicked RDP pharmacologically by simultaneous perfusion of the selective ATP1α3-blocker ouabain into the striatum and cerebellum of mice, followed by repeated exposure to mild motor stress. Ouabain-perfused RDP mice developed dystonia-like movements, which were exacerbated by exposure to sensorimotor stress. Compared to control mice, ouabain perfusion of the striatum led to dendritic spine loss of medium spiny neurons in addition to loss of cholinergic and GABAergic interneurons in the striatum. High-pressure liquid chromatography analyses revealed significant dopamine (DA) depletion and increased DA and serotonergic turnover, while qPCR analyses displayed reduction of glutamatergic receptors. Adding stress to the ouabain-predisposed brain, however, resulted in an elevation of the striatal DA metabolism back to the level of control animals. Our results indicate an ouabain-induced basal ganglia and cerebellar motor network dysfunction characterized by structural and neurochemical alterations of striatal dopaminergic, cholinergic and glutamatergic pathways that represent a motor endophenotype of RDP mutation carriers. Challenging the motor circuit by sensorimotor stress causes exacerbation of dystonia-like movements tightly linked to a hyperdopaminergic state in the striatum. Our observations support a gene-environment interaction or "second-hit" hypothesis in the symptomatogenesis of RDP.
"second-hit" hypothesis (Jankovic and Van der Linden, 1998; Kumar and Jog, 2011; Sheehy and Marsden, 1980; Wu and Jankovic, 2006) . Rapid-onset dystonia-parkinsonism (RDP, DYT/PARK-ATP1A3, DYT12) is a hereditary movement disorder caused by loss-of-function mutations in the gene encoding for the α3-subunit of the Na + /K + -ATPase (ATP1α3) (de Carvalho Aguiar et al., 2004) . Mutation carriers are most often asymptomatic until the teenage years, but suffer from an abrupt onset of a complex motor phenotype (Brashear et al., 2007) . Dystonia in RDP typically evolves with a rostro-caudal gradient, the parkinsonian features are characterized by bradykinesia and postural instability (Albanese et al., 2013) . Neither dopaminergic medication nor deep brain stimulation seem to be effective in RDP (Albanese et al., 2017) . As the penetrance of RDP is incomplete, and as disease onset is often preceded by a stressful event such as physical overexertion, fever, exposure to cold, trauma and excessive alcohol consumption (Barbano et al., 2012; Brashear et al., 2007) , gene-environment interactions may play crucial roles; however, the pathophysiology underlying this interplay is enigmatic.
Mutations affecting the Na + /K + -ATPase α3-subunit cause a loss of function with a reduction in protein expression as well as impaired ATPase activity in RDP patients, which presumably affects uptake and release of neurotransmitters such as dopamine (DA) (Heinzen et al., 2012; Toustrup-Jensen et al., 2014) . Transgenic RDP animal models have not sufficiently reproduced a stress-sensitive dystonic phenotype. In contrast, dystonic movements can reliably be achieved in wild type (wt) mice by infusion of the selective ATP1α3-blocker ouabain into the basal ganglia and cerebellum (Calderon et al., 2011) . In a previous study, creating the full RDP phenotype was dependent on simultaneous infusion of ouabain into the striatum and the cerebellum and additional exposure to stress, consisting of electric foot shocks (Calderon et al., 2011) . The cerebellum was identified as a key motor network component in the development of RDP in these mice, as electrophysiological recordings revealed irregularities in Purkinje cell activity . While similar aberrations have been seen in a transgenic RDP model, evidence suggests that abnormal cerebellar output alone is insufficient for dystonia development (Isaksen et al., 2017) . Aside from the cerebellum, the basal ganglia are believed to be strongly involved in RDP pathogenesis. An autopsy study reported neuron loss and gliosis in the basal ganglia and cerebellum in three symptomatic patients out of four siblings carrying the ATP1α3 mutation (Oblak et al., 2014) . Pathological changes of the basal ganglia have not been studied to date in a symptomatic RDP model, despite most models of dystonia positing altered striatal synaptic transmission and plasticity as necessary for the expression of dystonia.
This prompted us to analyze the basal ganglia for stress-dependent structural and metabolic changes in a symptomatic RDP mouse model. We hypothesized that ouabain, by blockade of the Na + /K + -ATPase α3subunit, renders the rodent brain vulnerable to stress and to a motor network dysfunction causing dystonia. In order to test this "second-hit" hypothesis, wt mice were perfused with ouabain into the basal ganglia and cerebellum and repeatedly exposed to a mild physical stressor by use of the Rotarod performance test and the Pole test. These motor tasks were implemented to elicit prolonged physical exercise since mild to moderate physical exercise are considered trigger for dystonia development in RDP patients (Barbano et al., 2012; Brashear et al., 1997; Brashear et al., 2007; Liu et al., 2016) . We here demonstrate the establishment of an RDP mouse model developing dystonia-like movements (DLM) upon mild motor stress, and showing dopaminergic dysregulation in a striatum hallmarked by microstructural changes.
Material and methods

Experimental animals
Male, wt C57BL/6N mice were purchased from Charles River at the age of 10 weeks. Surgery and behavioral testing were performed with mice at the age of 3 months. For chronic perfusion of the striatum and cerebellum with ouabain (Sigma Aldrich, St. Louisa, USA), two osmotic pumps (Alzet, model 1002, flow rate 0.25 μl/h, Durect, Cupertino, USA) were subcutaneously implanted onto the back of the mice and connected via tubing (Plastics One, Düsseldorf, Germany) to perfusion cannulas in both striata and the cerebellum. The perfusion cannulas were stereotaxically implanted as previously described (Calderon et al., 2011) . A double cannula with a c/c distance of 3.0 mm and custommade length of 4.0 mm (Plastics One, Düsseldorf, Germany) was bilaterally implanted into the striatum using the following coordinates from bregma: AP: 0.74 mm, ML: 1.50 mm and DV: 4.00 mm. A custom-made adaptor (Y21, Plastics One, Düsseldorf, Germany) was used to connect the double cannula to a single osmotic pump. A single cannula was implanted in the midline of the cerebellum at AP: −6.90 mm and DV: 3.00 mm with a cannula of 3.0 mm length. The osmotic pumps were primed and filled with either ouabain solution at a concentration of 11.2 ng/h, or 0.9% NaCl for the control group, according to the manufacturer's recommendation. Intraoperatively, as well as every 24 h during the observational period, mice were treated with carprofen. Mice were observed over a period of 72 h. All applicable international, national, and/or institutional guidelines for care and use of animals were followed. The local authorities at the Regierung von Unterfranken, Würzburg, Germany, approved all animal experiments.
Behavioral testing
Video recording for the dystonia rating scale
Due to the lack of predefined behavioral tasks to classify abnormal movements and postures in mice, an observer-based scoring system was established similar to the clinical rating scales of human dystonia. A 4min video was recorded before surgery and once every 24 h after implantation for a total observational period of 72 h and assessed by a trained investigator (L.R.) using the rodent motor score. This scoring system was introduced by Calderon and co-workers and modified to assess frequency and distribution of DLM from 0 to 4 points: (0) normal motor behavior; (1) abnormal motor behavior, no DLM; (2) mild motor impairment with mild focal DLM; (3) moderate motor impairment with severe focal DLM; (4) severe impairment, with sustained, generalized DLM (Calderon et al., 2011) .
Tail suspension test
The tail suspension test was performed preoperatively and once every 24 h for 72 h. Mice were suspended for 2 min per session by their tail, DLM were assessed using a newly developed rating scale from 0 to 8 points comprising the summed score of DLM in front limbs, hindlimbs and trunk (Table 1) .
Front limbs were scored from 0 to 4 points: (0) no abnormal movements; (1) reduced movement of front limbs with hyperextension of paws seen ≥ 50% of the recorded time; (2) mild DLM of front limb (s) < 50% of the recorded time; (3) mild DLM of front limb(s) ≥50% of the recorded time or severe < 50% of the recorded time; (4) severe DLM of front limb(s) ≥50% of the recorded time. Repeated or sustained tonic retractions of one or both front limbs, as well as tonic hyperextension combined with crossing of forelimbs, were classified as DLM. Hindlimbs were scored from 0 to 3 points: (0) no abnormal movements;
(1) reduced movement of hindlimbs with hyperextension of paws seen ≥50% of the recorded time; (2) DLM of one hindlimb; (3) DLM of both hindlimbs. Retraction and clenching of rear limbs as well as sustained hyperextension were classified as DLM. One point was given if truncal distortion was seen > 80% of the recorded time. A score < 2 indicated that no DLM were present. For all postoperative behavioral assessments, the rater was blinded to group assignment.
Open field analysis
Open field analysis was conducted preoperatively and once every 24 h for 72 h. A 10-min recording of mice placed in a box with L. Rauschenberger, et al. Experimental Neurology 323 (2020) 113109 dimensions 39.5 × 39.5 cm was performed using a video tracking software (EthoVision XT, Noldus, Wageningen, the Netherlands).
Stress exposure
Ouabain-and vehicle-perfused animals were subjected to the Rotarod performance test 4 h after surgery and every 24 h for 72 h. Mice performed three times per session on an accelerating Rotarod (RotaRod Advanced, TSE Systems, Bad Homburg, Germany) from 5 to 50 rpm for up to 300 s. This was immediately followed by the Pole test. Mice were placed facing downwards on top of a vertical, rough-surfaced pole of 50 cm height. The animals descended the pole three times.
Tissue analysis
Tissue analysis was performed after ouabain perfusion into striatum and cerebellum for 72 h. Golgi Cox staining of medium spiny neurons (MSN) was performed with the FD Rapid GolgiStain™ Kit (FD NeuroTechnologies, Columbia, USA). Striatal tissue was prepared and stained as recommended by the manufacturer. MSN were traced with the Neurolucida software (MBF Bioscience, Williston, USA) using the Olympus BX53 microscope (Olympus, Hamburg, Germany) and motorized stage. MSN were quantified via Sholl analysis. The selection of neurons was done randomly in the striatum of both hemispheres, with four neurons being analyzed for each animal (i.e. 12 neurons per group). For neuron tracing, cell body and all dendrites of the MSN had to be fully impregnated without any major overlay by other neurons. Any protrusion along a dendrite was traced as a spine. The experimenter was blinded to the group analyzed.
For preparation of fixed brain tissue, mice were transcardially perfused with phosphate buffered saline (PBS)/heparin followed by perfusion with 4% paraformaldehyde (PFA) in PBS for 15 min. The tissue was post-fixed in 4% PFA overnight and rinsed in 30% sucrose/PBS for 2 days at 4°C. The tissue was then embedded in TissueTec and cut into 40 μm-thick cross-sections on a cryostat (Leica, Solms, Germany) at −20°C. To ensure uniformity of staining, each stain was conducted in parallel with an entire series of sections spaced at 400 μm intervals. Immunohistochemistry was done using rabbit anti-parvalbumin (PV) (Abcam, Cambridge, UK), rabbit anti-choline acetyltransferase (ChAT) (Merck Millipore, Burlington, USA) and rabbit anti-neuronal nitric oxide synthase (nNOS) (Immunostar, Hudson, USA) antibodies. Quantification of the number of neurons was done with an Olympus BX53 microscope (Olympus, Hamburg, Germany) under a 100×/1.25 numerical aperture objective. Unbiased Stereology was performed with the Stereo Investigator software (version 11.07; MicroBrightField Biosciences, Williston, VT). Counting parameters were: grid size 110 × 110 μm, counting frame 50 × 50 μm and 1.5 μm guard zone. Gundersen coefficient of error for m = 1 was ≤ 0.09 for each section counted.
High-performance liquid-chromatography (HPLC)
72 h after surgery, mice were transcardially perfused with 0.1 M PBS and heparin. After dissection, both striata were rapidly frozen in liquid nitrogen and homogenized in 150 mM H 3 PO 4 and 500 μM diethylenetriaminepentaacetic acid with the Sonopuls Ultrasonic homogenizer (Bandelin, Berlin, Germany). After centrifugation with 20,817 g for 15 min, 5 μl of the supernatant were transferred to a Nucleosil 120-5 C18 column (250 mm × 4 mm, 5 μm; Macherey-Nagel, Düren, Germany). The mobile phase was composed of 0.975 mM octanesulphonic acid, 0.5 mM triethylamine, 0.1 mM ethylenediaminetetraacetic acid, 2 mM KCL, 0.09 M Na 2 HPO 4 and 14% methanol at a pH adjusted to 3.88 with phosphoric acid. The measurements were performed at 37°C and an electrode potential of +0.77 V versus the Ag/AgCl reference electrode using the Agilent 1260 LC System. 2,3-Dihydroxybenzoic acid was used as an internal standard. We analyzed Table 1 Scoring for dystonia-like movements (DLM) in a tail suspension test. Scoring of DLM of front limbs, hindlimbs and trunk from 0 to 8 points according to severity and duration. the striatum for DA and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), as well as serotonin (5-HT), 5hydroxyindoleacetic acid (5-HIAA) and noradrenaline (NA). An external standard calibration was used for quantification. The amount of total protein was determined by Lowry reagent and the results were normalized to neurotransmitter levels found in vehicle-perfused animals.
Western blot
Protein samples of the striatum were prepared as already described for HPLC analysis. Total protein concentration was assessed by Lowry assay. Proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Membranes were blocked with 5% milk in TBST and incubated with primary antibodies overnight at 4°C (dopamine transporter (DAT) and GAPDH, both Merck Millipore, Burlington, USA). Incubation with HRP-conjugated secondary antibodies was performed for 1 h at room temperature and visualization was achieved by the use of ECL reagent (Western Lightning Plus-ECL, PerkinElmer, Waltham, MA, USA). Image Lab software (version 6.0.1, Bio-Rad, Hercules, CA, USA) was used for data analysis. DAT protein levels were normalized to the endogenous control GAPDH and further to vehicle-perfused animals. (Table 1) . Front limb DLM with hyperextension and crossing of forelimbs (g) and tonic flexion (h) were scored depending on severity and duration of the abnormal movement; hindlimb DLM was scored in case of hyperextension as well as retraction with extension over the midline (i). (j) s-NaCl mice (dotted black line, n = 11 for all time points), ns-RDP mice (dotted blue line, n = 18 at 24 h postsurgery, n = 15 at 48 h and 72 h post-surgery), and s-RDP mice (red line, n = 23 at 24 h post-surgery, n = 19 at 48 h and 72 h post-surgery) are depicted; n indicates the number of biologically-independent animals, mean values for each time point ± SEM are shown. Statistical analysis was done using the two-tailed Mann-Whitney test. Bonferroni-Holm correction ( §) of the p-values showed a significant difference for the observational period of 72 h. *p < .05; **p < .01; ***p < .001; ****p < .0001 (red * denote significant differences between s-RDP mice and ns-RDP mice, black * denote significant differences between s-NaCl mice and ns-RDP mice and between s-NaCl mice and s-RDP mice). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) L. Rauschenberger, et al. Experimental Neurology 323 (2020) 113109 (caption on next page) Fresh frozen striatum and substantia nigra were disrupted with the TissueLyser LT (Qiagen, Hilden, Germany) and RNA isolated using the RNeasy Micro Kit (Qiagen) according to the manufacturer's guidelines. RNA concentration was quantified using a NanoDrop (Thermo Fischer Scientific, Waltham, USA). 100 ng of RNA was reverse transcribed in a 20 μl reaction using random octamers and oligo (dT)16 (High-Capacity RNA-to-cDNA™ Kit, Thermo Fischer Scientific, Waltham, USA). The DNA samples were analyzed as triplicates using TaqMan® assays and TaqMan® universal PCR master mix (Applied Biosystems, Foster City, USA). The 2 -ΔΔCT method was used to analyze the gene expression level. The results were normalized to glycerinaldehyd-3-phosphat-dehydrogenase (Gapdh) and further to mRNA levels of vehicle-perfused animals.
Statistical analysis
For statistical analysis, the distribution of the values was investigated via Q-Q-plots and the Shapiro-Wilk normality test. In case of non-normal distribution, the Mann-Whitney test was used when comparing two groups for each time point. This was followed by Bonferroni-Holm correction, as multiple time points were investigated ( §). Results are reported as mean ± standard error of the mean (SEM). The difference to the preoperative values was calculated to analyze the change over time. To compare multiple groups, the Kruskal-Wallis-test with Dunn's multiple comparison test was applied for plots showing non-normal distribution. In case of Gaussian distribution, the one-way ANOVA and Tukey's multiple comparison test was used. Data were considered not statistically different (ns) from the control group if p > .05. Statistical analysis for the Sholl assessment of MSN was performed for every 20 μm. In case of statistical significance, (*) is used to denote p < .05, (**) to denote p < .01, (***) to denote p < .001, and (****) to denote p < .0001.
Results
Mild motor stress after ouabain perfusion leads to a phenotypic mouse model for RDP
The concomitant perfusion of ouabain into the striatum and the cerebellum at a concentration of 11.2 ng/h each led to the development of stress-sensitive motor symptoms in mice. Ouabain-perfused, nonstressed (ns-RDP) mice showed slight bradykinesia as well as mild gait disturbance within a few hours after perfusion. In a 4-min video recording, DLM were evaluated according to body distribution and frequency with a modified dystonia rating scale ( Fig. 1a-e ). After 24, 48 and 72 h of ouabain perfusion, the dystonia rating scale of mice exposed to stress revealed a significantly higher score compared to ns-RDP mice and to NaCl-perfused, stressed (s-NaCl) mice. Additional movie files show the described motor phenotype in more detail (Video files A.1-3). Since RDP is a dystonia-plus syndrome, with patients suffering from additional parkinsonian symptoms, open field analysis served to evaluate bradykinesia in mice (Fig. 1f ). Ouabain-perfused, stressed (s-RDP) mice exhibited significantly less locomotor activity in the open field analysis compared to baseline (preoperative) than ns-RDP or s-NaCl mice at the 24, 48 and 72 h time points.
In a 2-min tail suspension test, DLM were scored from 0 to 8 points according to frequency and duration (Table 1) . Abnormal front limb movements seen in RDP mice were hyperextension with crossing of forepaws (Fig. 1g) , as well as tonic flexion of forepaws with retraction towards the chest of one or both limbs (Fig. 1h ). Hyperextension and retraction of the hindlimb and tonic flexion of the toes were scored as DLM (Fig. 1i ). Over the observational period of 72 h, DLM seen in the front and hindlimbs and in the trunk revealed a significantly stronger dystonia-like phenotype in s-RDP mice compared to ns-RDP and s-NaCl mice (Fig. 1j ). Additional movie files show the described DLM seen in the tail suspension test in more detail (Video files A.4 -6). In summary, mild motor stress as environmental factor exacerbates a dystonia-like phenotype in mice after ouabain perfusion of the striatum and cerebellum, thereby supporting the proposed "second-hit" hypothesis of dystonia pathophysiology.
Ouabain induces structural alterations of striatal MSN, cholinergic and GABAergic interneurons as a possible susceptibility factor for RDP
To assess the impact of ouabain with or without stress on striatal neurons, we analyzed the MSN and interneurons. Golgi Cox stainings followed by Sholl analyses of MSN did not reveal any differences in cell soma size in s-RDP mice compared with ns-RDP and s-NaCl animals ( Fig. 2a-c) . However, high-resolution analyses of dendritic spines by Golgi Cox stainings displayed a significantly reduced spine number and spine density (calculated as spine number/dendrite length) at a distance of 20-160 μm and of 20-100 μm from the soma center, respectively, in both RDP animal groups compared to the control mice ( Fig. 2d,e ). No significant changes of dendrite number or dendrite length in both RDP groups compared to s-NaCl mice were observed ( Fig. 2f,g) . Of note, stress application in RDP mice did not lead to any additional structural alterations of dendritic spine number and distribution. qPCR assessment of the DA and cyclic AMP-regulated phosphoprotein (Darpp-32), as marker for MSN, resulted in a reduction of mRNA level in both RDP groups to 76-80% compared to control animals ( Fig. 2h) .
As for striatal interneurons, unbiased stereology revealed a significant reduction of striatal ChAT-positive interneurons in both RDP mouse groups compared to the s-NaCl control group (Fig. 3a-d) . Striatal GABAergic nNOS-positive and PV-positive interneurons in s-RDP and ns-RDP groups showed a~30% and~40% reduction compared to s-NaCl animals, respectively ( Fig. 3e-h , i-l). Taken together, these data demonstrate structural alteration of striatal MSN as well as of cholinergic and GABAergic interneurons in RDP mice induced by ouabain treatment alone, independent from environmental stress as a putative predisposing intrinsic factor for dystonia development.
Stress induces dopaminergic dysregulation in the striatum of RDP mice but not in NaCl controls
In ns-RDP mice, HPLC analysis revealed a significant depletion of striatal DA levels and an elevated DA turnover, indicated by increase of DOPAC/DA and HVA/DA ratios that were induced by ouabain treatment in comparison to the s-NaCl control group (Fig. 4a,d,e ). Interestingly, motor stress in s-RDP mice restored the DA concentration almost to control levels (Fig. 4a ). In addition, after stress exposure a significant increase in the relative levels of the DA metabolites DOPAC Fig. 2 . Ouabain perfusion leads to microstructural changes of striatal medium spiny neurons (MSN). Sholl analysis was performed after tracing MSN visualized through Golgi-Cox staining comparing stressed (s)-NaCl (light grey, n = 12 neurons, 3 animals), non-stressed (ns)-rapid-onset dystonia-parkinsonism (RDP) mice (dark grey, n = 12 neurons, 3 animals), and s-RDP mice (dotted light grey, n = 12 neurons, 3 animals) (a,b). Cell volume (c), number of spines (d), spine density (e), number of dendrites (f), and dendritic length (g) are displayed in s-NaCl control mice, ns-RDP, and s-RDP animals. (h) Darpp-32 mRNA levels in all three groups of mice are displayed (s-NaCl vs ns-RDP: p = .44; s-NaCl vs s-RDP: p > .99). Mean values for each time point ± standard error of the mean (SEM) are shown. Statistical analysis was done using one-way ANOVA (c,e) and Kruskal-Wallis test for every 20 μm (d, f-h). *p < .05; **p < .01 (grey * denote significant differences between s-NaCl mice and ns-RDP mice, black * denote significant differences between s-NaCl mice and s-RDP mice). and HVA in s-RDP mice was recorded compared to s-NaCl controls (Fig. 4b,c ). DA is a direct precursor of NA, however NA showed no alterations in neurotransmitter levels between RDP animals and the control group as assessed by HPLC (Fig. 4f ). mRNA levels of DA receptors D1-D5 were also determined via qPCR ( Fig. 4g-k) . No change in expression was found for D1-like receptors (Drd1, Drd5) and D2-like receptors (Drd2, Drd3). Strikingly, a main effect of ouabain perfusion was observed for Drd4, which was significantly upregulated in the ns-RDP group compared to s-NaCl control mice and downregulated again after stress exposure (Fig. 4j ). mRNA and protein levels of Dat, responsible for DA reuptake from the synaptic cleft into the presynaptic dopaminergic terminal and thereby fast regulation of DA metabolism and of vesicular monoamine transporter 2 (Vmat2)important for the transport of neurotransmitters like DA and 5-HTdid not display any significant differences when the three groups of mice were compared ( Fig. 4l-n) . The two rate-limiting enzymes in DA synthesis, tyrosine hydroxylase (Th) and dopa decarboxylase (Ddc), were not significantly altered in mRNA expression levels in the different groups analyzed (Fig. 4o,p) .
In contrast to RDP mice, striatal levels of DA and DA metabolites in s-NaCl controls did not differ from NaCl-perfused mice without exposure to stress (ns-NaCl) ( Fig. 5a-e ). These data point towards a complex dopaminergic dysregulation in the striatum of mice after ouabain perfusion, and an additional impact of motor stress on the dopaminergic metabolism in dystonic s-RDP mice.
Indication for striatal serotonergic and glutamatergic imbalance in RDP mice
To assess other potentially altered neurotransmitters and receptors in striatal tissue, additional HPLC and qPCR analyses were performed. Striatal 5-HT was reduced in ns-RDP mice while 5-HT turnover, depicted by the 5-HIAA/5-HT ratio, was significantly elevated in ns-RDP animals compared to the s-NaCl group (Fig. 6a,b ). Stress administration in s-RDP mice led to an elevation of 5-HT and decrease of 5-HT turnover. The 5-HT receptors 5-hydroxytryptamine 1A and 2A (Htr1a/2a) did not show significantly altered mRNA levels in RDP animals compared to controls (Fig. 6c,d) . Furthermore, mRNA-levels of ionotropic glutamate receptors showed stress-dependent changes for the subunit 4 of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (Ampa4) and the subunit 2b of N-methyl D-aspartate receptor (Nmdar2b), but not for the other subunits assessed (Fig. 6e-k) . For Ampa4 and Nmdar2b a significant downregulation of glutamate receptors was found in the ns-RDP group compared to control mice. In comparison to the ns-RDP group, subjection to stress led to upregulation by~30% for Ampa4 receptors and~40% for Nmdar2b receptors. No changes in mRNA expression levels were found for metabotropic glutamatergic receptors mGluR1 and mGluR5 (Fig. 6l, m) . Striatal tissue was analyzed via qPCR for mRNA levels of dopaminergic receptors Drd1-5 of s-NaCl (light grey, n = 5), ns-RDP mice (n = 8, dark grey) and s-RDP mice (dotted light grey, n = 8). (l,m) Dopamine transporter (Dat) mRNA levels were analyzed in the substantia nigra in s-NaCl animals (light grey, n = 7), ns-RDP mice (n = 5, dark grey) and s-RDP mice (dotted light grey, n = 5); DAT protein levels were determined in the striatum via western blot in s-NaCl animals (light grey, n = 4), ns-RDP mice (n = 8, dark grey) and s-RDP mice (dotted light grey, n = 8). (n-p) Vesicular monoamine transporter 2 (Vmat2), tyrosine hydroxylase (Th) and dopa decarboxylase (Ddc) expression were analyzed in the substantia nigra in s-NaCl animals (light grey, n = 7), ns-RDP mice (n = 5, dark grey) and s-RDP mice (dotted light grey, n = 5). n indicates the number of biologically-independent animals. Single values and mean values for each time point ± standard error of the mean (SEM) are shown. Statistical analysis was done using one-way ANOVA followed by Tukey's post-test (a-f) and the Kruskal-Wallis test followed by Dunn's post-test (g-p). *p < .05, **p < .01.
Discussion
To assess the impact of environmental stressors on dystonia pathophysiology, we generated a phenotypic RDP mouse model by perfusion of the selective ATP1α3-blocker ouabain into the basal ganglia and cerebellum of mice, followed by repeated exposure to challenging motor tasks. Triggering events described for RDP patients include mild to moderate exercise, in particular running has been reported to precede symptom onset (Barbano et al., 2012; Brashear et al., 1997; Brashear et al., 2007; Liu et al., 2016) . In order to expose ouabain-and NaCl-perfused mice to prolonged physical exercise, animals were placed onto a Rotarod apparatus. This was followed by placing the mice on top of a wooden pole, which was chosen due to the observation that ouabain-perfused mice showed DLM during descent. Treatment with ouabain alone led to structural alterations in the striatum of mice, affecting both MSN and interneurons indicative for a predisposition that renders the brain vulnerable to stress, and thereby to the development of dystonia-like symptoms. Ouabain infusion by itself caused only a mild motor phenotype, which was seen in a similar manner in the mouse model of Calderon et al. and reflects the antecedent mild motor symptoms some RDP mutation carriers present before primary onset of RDP (Brashear et al., 2007; Calderon et al., 2011) . Additional administration of sensorimotor stress induced dysregulation of the dopaminergic metabolism in the striatum and led to pronounced dystonia-like symptoms. Our results thus underline the importance of the interaction between environmental and intrinsic predisposing factors in dystonia pathophysiology, as proposed by the "second-hit" hypothesis.
Disturbed sensorimotor pathways of the basal ganglia and cerebellum are thought to play a central part in dystonia pathophysiology (Schirinzi et al., 2019) . Dystonia studies have delivered direct evidence for a close interaction and possible combined dysfunction of the cerebellum and the basal ganglia (Chen et al., 2014; Neychev et al., 2008) . Indeed, Chen et al. hypothesized that the appearance of abnormal motor patterns in this pharmacological RDP model is driven by the cerebellum, which in turn influences basal ganglia activity via a cerebello-thalamo-basal ganglia synaptic pathway (Chen et al., 2014) . While lesioning the deep cerebellar output nuclei in the present RDP model led to reduction of the dystonic symptoms, the basal ganglia were shown to be imperative for the full dystonia-like phenotype (Calderon et al., 2011) . It remains unclear whether the cerebellar dysfunction seen in this RDP model is the primary driver of dystonic symptoms or the result of failing compensatory mechanisms. Since the cerebellum has been thoroughly studied in the currently used pharmacological RDP model (Calderon et al., 2011; Fremont et al., 2014) , we here focused on the involvement of the basal ganglia in RDP pathophysiology. The exact mechanisms underlying the basal ganglia involvement in dystonia are still unclear, but alterations of striatal plasticity were suggested to play an important role (Maltese et al., 2018; Vitek et al., 1999; Zhuang et al., 2004) . Analysis of the striatal neuronal population of our RDP model revealed a non-significant reduction in relative mRNA level of Darpp-32, as a marker for MSN, to 76-80% in both RDP groups compared to control animals. A neuronal loss of < 20% at an ouabain dosage of 36 ng/h has previously been described due to neurotoxicity in the regions closest to the cannula . Although the affected neuron population was not determined, the mainly affected neurons are supposed to be the MSN that account for 95% of striatal neurons. A significantly reduced density of Nissl-stained cells, which was greatest at the cannula insertion site, but can be seen throughout the entire striatum, supports a substantial cell loss in ouabain-perfused mice compared to the control group (Appendix B : Fig. B.1) . Microstructural analysis of MSN in our RDP model demonstrated that dendrite number and length were comparable to vehicle-perfused animals. Strikingly, our model showed a significantly lower MSN spine number and consequently a reduced spine density over the entire dendrite length, independent from stress in both RDP groups compared to control animals. MSN spines receive excitatory glutamatergic synaptic inputs from the thalamus and the cerebral cortex, as well as dopaminergic inputs from midbrain neurons. Accordingly, a close synaptic interaction of glutamatergic and dopaminergic synapses correlates to striatal synaptic plasticity (Moss and Bolam, 2008; Smith et al., 1994) . Thereby, alteration of dendritic spines in the RDP model reflects an alteration of striatal synaptic plasticity that is described as one of the pathophysiologic concepts of dystonia (Peterson et al., 2010; Quartarone and Hallett, 2013) . Synaptic plasticity in the striatum also shapes synapses of striatal interneurons that are known to modulate MSN function (Martella et al., 2009 ). Unbiased stereology revealed a loss of GABAergic striatal interneurons in both ouabain-perfused groups. Concomitant analyses of Nissl+ profiles and interneuronal stainings indicated that this loss was an actual loss of cells and not a down-regulation of phenotypic markers (Appendix B :  Fig. B.1-4) . GABAergic nNOS-positive interneurons are suggested to massively influence striatal circuits through nitric oxide as a key neuromodulator with an important role in processes such as release and uptake of neurotransmitters and synaptic plasticity, and thereby to elicit a crucial role in motor control (Kiss, 2000; Park and West, 2009; Pierucci et al., 2011) . Similar to a pathomechanism described in dystonic dt sz hamsters, reduced feedforward inhibition of GABAergic PVpositive interneurons on MSN in ouabain-perfused mice might entail disinhibition of the striatal output neurons, thereby supporting another pathophysiologic concept of dystonia development, described as the loss of inhibition (Gernert et al., 2000; Quartarone and Hallett, 2013) . Next to GABAergic interneurons, the numbers of cholinergic ChATpositive interneurons were also severely affected by cell loss in our RDP model. While no evidence exists for RDP, in a DYT1 mouse model, striatal cholinergic interneurons degenerated in juvenile rodents, which directly correlated with the development of abnormal movements (Pappas et al., 2015) . These and other mouse models for dystonia still benefited from anticholinergic medication, suggesting a dysfunction of striatal cholinergic interneurons, rather than a sheer lack of cholinergic neurotransmission as part of the dystonia pathophysiology (Eskow Jaunarajs et al., 2015; Maltese et al., 2014; Pappas et al., 2015) . Most forms of dystonia responding to treatment with anticholinergic medication is another clear indication for the importance of the cholinergic system (Burke et al., 1986; Fahn, 1983 ). Furthermore, it was described that striatal acetylcholine can influence synaptic plasticity on MSN via muscarinic receptors (Martella et al., 2009; Wang et al., 2006) .
Of note, a complex interaction between acetylcholine and DA systems in the striatum has been described. While DA is suggested to reduce acetylcholine release, a reciprocal effect of acetylcholine on DA has been shown (Cachope et al., 2012; Threlfell et al., 2012) . Next to acetylcholine, DA is also known to be pivotal in maintaining MSN synapses. Dendritic spine loss is found in the striatum of patients with Parkinson's disease, where the extent of spine reduction correlates with the extent of striatal dopaminergic denervation, but not with the degree of motor symptoms Zaja-Milatovic et al., 2005) . In Parkinson's disease, it is unclear whether this striatal spine loss is simply a consequence of DA depletion or if it represents a compensatory mechanism Villalba and Smith, 2013) . Our data support the hypothesis that reduction in MSN spine density and striatal interneuron loss in symptomatic and non-symptomatic RDP animals could reflect a pathogenic endophenotype in genetic RDP, leading to aberrant synaptic plasticity, loss of inhibition, and altered integration and processing of striatal input.
The role of aberrant striatal dopaminergic neurotransmission in dystonia pathophysiology is widely accepted, because inherited defects of DA synthesis altering dopaminergic neurotransmission are wellknown causes of dystonia (Lohmann and Klein, 2013; Phukan et al., 2011) . Furthermore, DA dysregulation, with an increase of dopaminergic neurotransmission and development of a dystonic phenotype in response to nerve injury, was evident in a mouse model of DYT1 (Ip et al., 2016) . Other DYT1 mouse models without a dystonic phenotype, such as DYT1 knock-in mice and hΔGAG mice, did not reveal striatal changes in DA or DOPAC level (Dang et al., 2005; Grundmann et al., 2007) . In our RDP mice, the striatum of non-dystonic ouabain-perfused mice without exposure to stress revealed a significant depletion of DA and a significantly increased DA turnover compared to vehicle-perfused animals, indicative of an endophenotypic correlate of a hypodopaminergic network disorder.
An important pathomechanism in RDP is the interplay between environmental factors and predisposition for dystonia development. Strikingly, after exposure to motor stress a complex dysregulation of striatal DA metabolism was observed in ouabain-treated mice, with a significant increase in DA and metabolite levels and alteration of DA turnover compared to ns-RDP mice. Supporting this finding, microdialysis studies in animals showed an increase in striatal DA in response to stressors such as electric shocks or tail pinch (Abercrombie et al., 1989; Rougé-Pont et al., 1998) . However, we did not observe changes in DA levels when comparing NaCl-perfused animals with and without exposure to motor stress, indicative of a higher vulnerability of the striatum to stress exposure after ouabain treatment. A dysregulation of the striatal DA system is also found in another hyperkinetic phenomenon, the levodopa-induced dyskinesias in Parkinson's disease. Here, dopaminergic depletion entails impaired synaptic plasticity through loss of dendritic spines and changes in spine morphology, as well as a modification of the DA receptor-signaling cascades through hypersensitization (Carta et al., 2008; Heumann et al., 2014; Villalba et al., 2009 ). Since DA also tightly regulates the activity of cholinergic interneurons, one of the pathomechanisms involved in the expression of levodopa-induced dyskinesias is thought to be an imbalance between the dopaminergic and cholinergic system through an enhanced cholinergic excitability (Ding et al., 2011 )a process that similarly could play a role in dystonia (Eskow Jaunarajs et al., 2015) .
Some changes to the sensorimotor circuitry of RDP mice might represent compensatory mechanisms for pathological alterations; others again might be secondary to the development of DLM. Such compensatory mechanisms might include the significant upregulation of DRD4 in ns-RDP mice. To our knowledge, there are no postmortem studies of Drd4-expression on human brain tissue for dystonia, but analyzes on hyperkinetic (Huntington's) and hypokinetic (Parkinson's disease) movement disorders couldn't report any changes of receptor expression (Tarazi and Baldessarini, 1999) . In our case, RDP mice with especially low striatal DA levels were the ones with the highest DRD4 mRNA levels (data not shown). In DRD4-deficient mice striatal DA synthesis and turnover as well as extracellular glutamate levels were found to be increased (Currier et al., 2009; Rubinstein et al., 2001; Rubinstein et al., 1997) . A previously published D4.7 mouse model with a DRD4 polymorphism leading to a gain of function of the receptor revealed a reduced response to methamphetamine (Bonaventura et al., 2017) . No difference in basal DA or glutamate level was found in D4.7 mice compared to wt animals, however, methamphetamine caused a significantly lower increase of these neurotransmitters in tg mice. Moreover, it was shown that DRD4 receptor activation inhibits corticostriatal glutamatergic neurotransmission (Bonaventura et al., 2017) . This suggests an important modulating role of DRD4 not only in dopaminergic, but also in corticostriatal excitatory glutamatergic neurotransmission. In line with this finding, a significant downregulation of glutamatergic receptors Ampa4 and Nmdar2b was seen in ns-RDP mice compared to s-NaCl control mice. In particular, the reduction in NMDA-receptors could further influence the dopaminergic and cholinergic environment of the striatum (Consolo et al., 1996; Grace, 2016) . The same holds true for the increased serotonin turnover in RDP mice. This phenomenon has been described before as a consequence of DA depletion in animal studies (Karstaedt et al., 1994) .
Our data highlight for the first time a stress-dependent dopaminergic dysregulation in RDP. However, a limitation of our study is that HPLC measurement of catecholamine levels in striatal tissue does not distinguish extracellular from intracellular DA levels. In order to further explore the role of the basal ganglia in RDP development, additional studies are needed to understand the mechanisms behind the disturbed DA homeostasis. In addition, it is difficult to perform proof-of-principle experiments regarding the role of striatal DRD4 because of the lack of DRD4 blocking compounds or knock-out mice with striatal specificity. Other structures believed to be involved in RDP pathogenesis, such as the substantia nigra and thalamus, need to be studied as well. Functional studies specifically targeting striatal interneurons, midbrain DA and cortical glutamatergic inputs, as well as MSN, are required in this dystonia model. However, considering the limitations in studying basal ganglia dysfunctions in human RDP patients, our phenotypic mouse model deepens our understanding of dystonia pathogenesis.
Conclusions
In summary, we have generated a symptomatic RDP mouse model highly susceptible to developing severe DLM after exposure to a mild physical stressor. This highlights the key role of environmental factors in RDP development and emphasizes the implication of basal ganglia disturbance in RDP pathogenesis. We propose that the structural alterations affecting the MSN and striatal interneurons that were found in RDP mice independent of stress are a possible indication for disturbed brain integrity, and could constitute a susceptibility factor in ATP1α3 mutation carriers and, as such, represent a possible endophenotype. Compensatory mechanisms are needed to prevent the development of DLM in non-manifesting RDP mice. Stress-sensitive dopaminergic dysregulation might play a central part in the development of DLM in dystonia-parkinsonism.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.expneurol.2019.113109.
Declaration of Competing Interest
The authors report no conflicts of interest.
